A phase 1 trial of imatinib mesylate in combination with daunorubicin and cytarabine for patients for c-kit positive relapsed acute myeloid leukemia (AML)

被引：0
|
作者：
Advani, Anjali S. [1 ]
Sobecks, Ronald [1 ]
Sekeres, Mikkael A. [1 ]
Copelan, Ed [1 ]
Bates, Jennifer [1 ]
Tripp, Barbara [1 ]
Salvado, August [2 ]
Kalaycio, Matt [1 ]
机构：
[1] Cleveland Clin, Leukemia Program, Cleveland, OH USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.906.906
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
906
引用
收藏
页码：276A / 276A
页数：1
相关论文
共 50 条
  • [41] Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a C-KIT exon 8 mutation
    T Nanri
    N Matsuno
    T Kawakita
    H Mitsuya
    N Asou
    Leukemia, 2005, 19 : 1673 - 1675
  • [42] Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and C-KIT exon 8 mutation
    Asou, N
    Nanri, T
    Matsuno, N
    Kawakita, T
    Suzushima, H
    Mitsuya, H
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 75 - 75
  • [43] Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a C-KIT exon 8 mutation
    Nanri, T
    Matsuno, N
    Kawakita, T
    Mitsuya, H
    Asou, N
    LEUKEMIA, 2005, 19 (09) : 1673 - 1675
  • [44] Remission in a patient with c-kit positive refractory acute myelogenous leukemia after imatinib treatment
    Yildirim, Z
    Grant, BW
    Liu, XLS
    Branda, RR
    Cushman, M
    Holmes, CE
    Tindle, BH
    BLOOD, 2002, 100 (11) : 266B - 266B
  • [45] CLOFARABINE IN COMBINATION WITH CYTARABINE (ARA-C) FOR TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN ADULT PATIENTS
    Malato, A.
    Santoro, A.
    Magrin, S.
    Felice, R.
    Turri, D.
    Di Bella, R.
    Salemi, D.
    Acquaviva, F.
    Scime, R.
    Fabbiano, F.
    HAEMATOLOGICA, 2012, 97 : 502 - 503
  • [46] Radotinib induces high cytotoxicity in c-KIT positive acute myeloid leukemia cells
    Heo, Sook-Kyoung
    Noh, Eui-Kyu
    Kim, Jeong Yi
    Jo, Jae-Cheol
    Choi, Yunsuk
    Koh, Sujin
    Baek, Jin Ho
    Min, Young Joo
    Kim, Hawk
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 804 : 52 - 56
  • [47] Cytarabine, daunorubicin and etoposide (ADE) chemotherapy in acute myeloid leukemia (AML) patients ≥60 years (CALGB 9720)
    Baer, Maria R.
    George, Stephen L.
    Sanford, Ben L.
    Bothun, Sandra M.
    Mrozek, Krzysztof
    O'Loughlin, Kieran L.
    Kolitz, Jonathan E.
    Moore, Joseph O.
    Stone, Richard M.
    Powell, Bayard L.
    Caligiuri, Michael A.
    Bloomfield, Clara D.
    Larson, Richard A.
    BLOOD, 2007, 110 (11) : 94A - 94A
  • [48] APP Gene Is Correlated with C-KIT Mutations and Indicates Poor Disease Outcome in AML1-ETO-Positive Acute Myeloid Leukemia
    Yu, Guopan
    Jiang, Ling
    Meng, Fan Yi
    Yin, Changxin
    Wang, Zhixiang
    Zhou, Hongsheng
    Jiang, Xuejie
    Zhong, Qingxiu
    Cao, Rui
    Liao, Libin
    BLOOD, 2014, 124 (21)
  • [49] The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study)
    Deau, Benedicte
    Nicolini, Franck E.
    Guilhot, Joelle
    Huguet, Francoise
    Guerci, Agnes
    Legros, Laurence
    Pautas, Cecile
    Berthou, Christian
    Guyotat, Denis
    Cony-Makhoul, Pascale
    Gardembas, Martine
    Michallet, Mauricette
    Hayette, Sandrine
    Cayuela, Jean Michel
    Weiss, Isabelle Radford
    Rea, Delphine
    Castaigne, Sylvie
    Mahon, Francois-Xavier
    Guilhot, Francois
    Rousselot, Philippe
    LEUKEMIA RESEARCH, 2011, 35 (06) : 777 - 782
  • [50] Phase I Trial of Escalating Doses of the Bcl-2 Inhibitor Venetoclax in Combination with Daunorubicin/Cytarabine Induction and High Dose Cytarabine Consolidation in Previously Untreated Adults with Acute Myeloid Leukemia (AML)
    Stone, Richard M.
    DeAngelo, Daniel J.
    Galinsky, Ilene
    Kokulis, Caroline
    Stewart, Jeremy M.
    McGinnis, Michael
    Werner, Lillian
    Letai, Anthony G.
    Konopleva, Marina Y.
    Luskin, Marlise
    BLOOD, 2019, 134
12345